- call +1-201-465-4211
- email sales@mrinsights.biz
For transferring the insulin a device is used that is known as insulin patch pump. Owing to the presence of the adhesive, the insulin patch pump gets directly attached to the body. The presence of the adhesive avoids the requirement of the infusion set and tubing for attaching the pump to the body.
Scope of the Report:
This report focuses on the Monoclonal Antibody Treatment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Monoclonal Antibody Treatment is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Pfizer
Bayer
Sanofi
Merck
GlaxoSmithKline
Roche
Novartis
AbbVie
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Cancer
Autoimmune Diseases
Infection
Hematological Diseases
Others
Market Segment by Applications, can be divided into
Hospitals
Clinics
Others
There are 15 Chapters to deeply display the global Monoclonal Antibody Treatment market.
Chapter 1, to describe Monoclonal Antibody Treatment Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Monoclonal Antibody Treatment, with sales, revenue, and price of Monoclonal Antibody Treatment, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Monoclonal Antibody Treatment, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Monoclonal Antibody Treatment market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Monoclonal Antibody Treatment sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Monoclonal Antibody Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Cancer
1.2.2 Autoimmune Diseases
1.2.3 Infection
1.2.4 Hematological Diseases
1.2.5 Others
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Monoclonal Antibody Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Monoclonal Antibody Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bayer
2.2.1 Business Overview
2.2.2 Monoclonal Antibody Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bayer Monoclonal Antibody Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Sanofi
2.3.1 Business Overview
2.3.2 Monoclonal Antibody Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Sanofi Monoclonal Antibody Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merck
2.4.1 Business Overview
2.4.2 Monoclonal Antibody Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck Monoclonal Antibody Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 GlaxoSmithKline
2.5.1 Business Overview
2.5.2 Monoclonal Antibody Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 GlaxoSmithKline Monoclonal Antibody Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Roche
2.6.1 Business Overview
2.6.2 Monoclonal Antibody Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Roche Monoclonal Antibody Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Novartis
2.7.1 Business Overview
2.7.2 Monoclonal Antibody Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Novartis Monoclonal Antibody Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 AbbVie
2.8.1 Business Overview
2.8.2 Monoclonal Antibody Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 AbbVie Monoclonal Antibody Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Monoclonal Antibody Treatment Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Monoclonal Antibody Treatment Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Monoclonal Antibody Treatment Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Monoclonal Antibody Treatment Manufacturer Market Share in 2017
3.3.2 Top 6 Monoclonal Antibody Treatment Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Monoclonal Antibody Treatment Market Analysis by Regions
4.1 Global Monoclonal Antibody Treatment Sales, Revenue and Market Share by Regions
4.1.1 Global Monoclonal Antibody Treatment Sales and Market Share by Regions (2013-2018)
4.1.2 Global Monoclonal Antibody Treatment Revenue and Market Share by Regions (2013-2018)
4.2 North America Monoclonal Antibody Treatment Sales and Growth Rate (2013-2018)
4.3 Europe Monoclonal Antibody Treatment Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Monoclonal Antibody Treatment Sales and Growth Rate (2013-2018)
4.5 South America Monoclonal Antibody Treatment Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Monoclonal Antibody Treatment Sales and Growth Rate (2013-2018)
5 North America Monoclonal Antibody Treatment by Countries
5.1 North America Monoclonal Antibody Treatment Sales, Revenue and Market Share by Countries
5.1.1 North America Monoclonal Antibody Treatment Sales and Market Share by Countries (2013-2018)
5.1.2 North America Monoclonal Antibody Treatment Revenue and Market Share by Countries (2013-2018)
5.2 United States Monoclonal Antibody Treatment Sales and Growth Rate (2013-2018)
5.3 Canada Monoclonal Antibody Treatment Sales and Growth Rate (2013-2018)
5.4 Mexico Monoclonal Antibody Treatment Sales and Growth Rate (2013-2018)
6 Europe Monoclonal Antibody Treatment by Countries
6.1 Europe Monoclonal Antibody Treatment Sales, Revenue and Market Share by Countries
6.1.1 Europe Monoclonal Antibody Treatment Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Monoclonal Antibody Treatment Revenue and Market Share by Countries (2013-2018)
6.2 Germany Monoclonal Antibody Treatment Sales and Growth Rate (2013-2018)
6.3 UK Monoclonal Antibody Treatment Sales and Growth Rate (2013-2018)
6.4 France Monoclonal Antibody Treatment Sales and Growth Rate (2013-2018)
6.5 Russia Monoclonal Antibody Treatment Sales and Growth Rate (2013-2018)
6.6 Italy Monoclonal Antibody Treatment Sales and Growth Rate (2013-2018)
7 Asia-Pacific Monoclonal Antibody Treatment by Countries
7.1 Asia-Pacific Monoclonal Antibody Treatment Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Monoclonal Antibody Treatment Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Monoclonal Antibody Treatment Revenue and Market Share by Countries (2013-2018)
7.2 China Monoclonal Antibody Treatment Sales and Growth Rate (2013-2018)
7.3 Japan Monoclonal Antibody Treatment Sales and Growth Rate (2013-2018)
7.4 Korea Monoclonal Antibody Treatment Sales and Growth Rate (2013-2018)
7.5 India Monoclonal Antibody Treatment Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Monoclonal Antibody Treatment Sales and Growth Rate (2013-2018)
8 South America Monoclonal Antibody Treatment by Countries
8.1 South America Monoclonal Antibody Treatment Sales, Revenue and Market Share by Countries
8.1.1 South America Monoclonal Antibody Treatment Sales and Market Share by Countries (2013-2018)
8.1.2 South America Monoclonal Antibody Treatment Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Monoclonal Antibody Treatment Sales and Growth Rate (2013-2018)
8.3 Argentina Monoclonal Antibody Treatment Sales and Growth Rate (2013-2018)
8.4 Colombia Monoclonal Antibody Treatment Sales and Growth Rate (2013-2018)
9 Middle East and Africa Monoclonal Antibody Treatment by Countries
9.1 Middle East and Africa Monoclonal Antibody Treatment Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Monoclonal Antibody Treatment Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Monoclonal Antibody Treatment Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Monoclonal Antibody Treatment Sales and Growth Rate (2013-2018)
9.3 UAE Monoclonal Antibody Treatment Sales and Growth Rate (2013-2018)
9.4 Egypt Monoclonal Antibody Treatment Sales and Growth Rate (2013-2018)
9.5 Nigeria Monoclonal Antibody Treatment Sales and Growth Rate (2013-2018)
9.6 South Africa Monoclonal Antibody Treatment Sales and Growth Rate (2013-2018)
10 Global Monoclonal Antibody Treatment Market Segment by Type
10.1 Global Monoclonal Antibody Treatment Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Monoclonal Antibody Treatment Sales and Market Share by Type (2013-2018)
10.1.2 Global Monoclonal Antibody Treatment Revenue and Market Share by Type (2013-2018)
10.2 Cancer Sales Growth and Price
10.2.1 Global Cancer Sales Growth (2013-2018)
10.2.2 Global Cancer Price (2013-2018)
10.3 Autoimmune Diseases Sales Growth and Price
10.3.1 Global Autoimmune Diseases Sales Growth (2013-2018)
10.3.2 Global Autoimmune Diseases Price (2013-2018)
10.4 Infection Sales Growth and Price
10.4.1 Global Infection Sales Growth (2013-2018)
10.4.2 Global Infection Price (2013-2018)
10.5 Hematological Diseases Sales Growth and Price
10.5.1 Global Hematological Diseases Sales Growth (2013-2018)
10.5.2 Global Hematological Diseases Price (2013-2018)
10.6 Others Sales Growth and Price
10.6.1 Global Others Sales Growth (2013-2018)
10.6.2 Global Others Price (2013-2018)
11 Global Monoclonal Antibody Treatment Market Segment by Application
11.1 Global Monoclonal Antibody Treatment Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Clinics Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 Monoclonal Antibody Treatment Market Forecast (2018-2023)
12.1 Global Monoclonal Antibody Treatment Sales, Revenue and Growth Rate (2018-2023)
12.2 Monoclonal Antibody Treatment Market Forecast by Regions (2018-2023)
12.2.1 North America Monoclonal Antibody Treatment Market Forecast (2018-2023)
12.2.2 Europe Monoclonal Antibody Treatment Market Forecast (2018-2023)
12.2.3 Asia-Pacific Monoclonal Antibody Treatment Market Forecast (2018-2023)
12.2.4 South America Monoclonal Antibody Treatment Market Forecast (2018-2023)
12.2.5 Middle East and Africa Monoclonal Antibody Treatment Market Forecast (2018-2023)
12.3 Monoclonal Antibody Treatment Market Forecast by Type (2018-2023)
12.3.1 Global Monoclonal Antibody Treatment Sales Forecast by Type (2018-2023)
12.3.2 Global Monoclonal Antibody Treatment Market Share Forecast by Type (2018-2023)
12.4 Monoclonal Antibody Treatment Market Forecast by Application (2018-2023)
12.4.1 Global Monoclonal Antibody Treatment Sales Forecast by Application (2018-2023)
12.4.2 Global Monoclonal Antibody Treatment Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Monoclonal Antibody Treatment Picture
Table Product Specifications of Monoclonal Antibody Treatment
Figure Global Sales Market Share of Monoclonal Antibody Treatment
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
